Related references
Note: Only part of the references are listed.An overview of prognostic factors for long-term survivors of breast cancer
Isabelle Soerjomataram et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen
Mahmoud R. Khoshnoud et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
DNA methylation: The nuts and bolts of repression
Tina Branscombe Miranda et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancer
J. W. Assender et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Protein kinase C and other diacylglycerol effectors in cancer
Erin M. Griner et al.
NATURE REVIEWS CANCER (2007)
Estrogen receptors: Role in breast cancer
M. J. Duffy
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2006)
How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study
AM Sieuwerts et al.
CLINICAL CANCER RESEARCH (2005)
Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer
JWM Martens et al.
CANCER RESEARCH (2005)
Upregulation of PKC-δ contributes to antiestrogen resistance in mammary tumor cells
SM Nabha et al.
ONCOGENE (2005)
The enigmatic protein kinase Cδ:: complex roles in cell proliferatin and survival
DN Jackson et al.
FASEB JOURNAL (2004)
An ELISA avoiding interference by heterophilic antibodies in the measurement of components of the plasminogen activation system in blood
N Grebenchtchikov et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Share Paper
